WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹1,235 Cr | ₹887 Cr | ₹617 Cr | ₹-22 Cr | ₹261 Cr |
What is the latest Total Non-Current Liabilities ratio of WOCKHARDT ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹1,235 Cr |
| Mar2025 | ₹887 Cr |
| Mar2024 | ₹617 Cr |
| Mar2023 | ₹-22 Cr |
| Mar2022 | ₹261 Cr |
How is Total Non-Current Liabilities of WOCKHARDT Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,235 Cr | 39.23 | |
| Mar2025 | ₹887 Cr | 43.76 | |
| Mar2024 | ₹617 Cr | Positive | |
| Mar2023 | ₹-22 Cr | Negative | |
| Mar2022 | ₹261 Cr | - | |
Compare Total Non-Current Liabilities of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹35,443.7 Cr | -1.2% | 13.9% | 52.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | -1.2% |
13.9% |
52.1% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses